France Life Science Trend Analysis 2024

The French life sciences industry continued to perform strongly in 2023, compared to other European countries like the Netherlands, Belgium, and Germany. Biotechnology companies make up 40% of the life sciences sector in France, with nearly half of these engaged in R&D services. Within the biotech – therapeutics and diagnostics sector, top key activities are … Continue reading France Life Science Trend Analysis 2024

Read more

Clinical Trials Overview 2024: Key Insights from Biotechgate

As the cornerstone of the biopharma industry, the clinical trials market is projected to reach a value of over USD 153 billion by 2033, according to Nova One Advisor. The Biotechgate clinical trials section, launched in 2019, currently lists over 920,000 studies and is continuously updated with new information for trials, covering both well-known areas … Continue reading Clinical Trials Overview 2024: Key Insights from Biotechgate

Read more

How to Successfully Manage Early-Stage Clinical Trials

The overall success rate of clinical trials is only 7.9%, highlighting the significant risks for biopharmaceutical companies when bringing a drug to market. Early-stage clinical trials determine the future development of a new drug and effective management at this stage is crucial for the success of new treatments and therapies. In this article, read about … Continue reading How to Successfully Manage Early-Stage Clinical Trials

Read more

Top mRNA Vaccines in Development

Having seen its popularity explode thanks to its utilization against COVID-19 in 2020, messenger RNA (mRNA) vaccines have been an increasing source of diversification for companies in the biopharma industry, including advantages over traditional drugs such as being easily programmable, while also reducing development risk and financial costs. This has led to the sector exploring … Continue reading Top mRNA Vaccines in Development

Read more

UK Life Science Trend Analysis 2024

The UK government published the Science & Technology Framework in early 2023, signaling a robust strategy for the growth of the science and technology sector, with a focus on increasing private investment in R&D. Potentially a result of this strategic push, biotech private equity funding experienced a slight rise both in terms of the amount … Continue reading UK Life Science Trend Analysis 2024

Read more

Norway Life Science Trend Analysis 2024

In 2023, the Norwegian life science industry continues to show dynamism and innovation. With biotechnology companies comprising a substantial 48% of the life science sector, nearly half of these fall under the “Biotech – Other” category, which includes sectors such as AgBio, environmental, veterinary, and industrial biotechnology. Notably, digital health emerges as a key sector, … Continue reading Norway Life Science Trend Analysis 2024

Read more

Introducing the New Version of Biotechgate

We are pleased to announce the upcoming launch of a new version of the Biotechgate database, scheduled for the end of May. The release features an enhanced user experience and several new functionalities, including a new M&A section and access to analyst reports and forecasts. In this article, be introduced to the potential of the … Continue reading Introducing the New Version of Biotechgate

Read more

Biotechgate Announces Collaboration with PharmaTell to Deliver Cutting-Edge Analyst Reports

ZURICH, Switzerland, May 2024 – Biotechgate, a leading provider of life sciences information and partnering solutions, is delighted to announce its strategic collaboration with PharmaTell, a respected provider of high-quality analyst reports covering the entire healthcare industry. This partnership aims to enhance the new version of the Biotechgate database by implementing PharmaTell’s analyst reports, providing … Continue reading Biotechgate Announces Collaboration with PharmaTell to Deliver Cutting-Edge Analyst Reports

Read more

Life Sciences M&A Report 2023

2023 showed slow signs of recovery for global life science M&A activity compared to the previous year, both in terms of the number and value of deals. While the macroeconomic challenges and uncertainty in the geopolitical landscape that fueled the 2022 slowdown carried over into 2023, there are indications that dealmakers were approaching 2023 with … Continue reading Life Sciences M&A Report 2023

Read more

Taiwan Life Science Trend Analysis 2024

While 2023 shows a declining trend in terms of private equity financing of Taiwanese life science companies since 2020, public financing surged year-on-year, raising more than twice as much as in 2022. The three largest private equity financing rounds in 2023 were completed by medical technology companies, led by Syncell, which raised USD 8 million. … Continue reading Taiwan Life Science Trend Analysis 2024

Read more